Efficacy and Safety of 3-Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases. Arase Y, Tsuruya K, Hirose S, Ogiwara N, et al. Hepatology 2020;71:757-759.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Arase Y, Tsuruya K, Hirose S, Ogiwara N, et al. Efficacy and Safety of 3-Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases. Hepatology 2020;71:757-759.
PMID: 31429969